UNC Lineberger gets $40M from OpenAI Foundation for cancer-vaccine AI data

UNC Lineberger Comprehensive Cancer Center said it received $40 million from the OpenAI Foundation to build clinical and biological datasets that can train AI models to pick better tumor targets for personalized cancer vaccines. The grant is part of the Foundation’s new Public Data for Health program, which funds open-access scientific datasets for life-science and disease research.

Same-day HEALTH primary that a major AI lab’s nonprofit parent is funding open biological datasets — not another chatbot feature — so models can learn from real tumor and immune data for personalized cancer vaccines. HEALTH desk priority: AI × cancer research with a named dollar figure and open-data intent.

UNC Lineberger Comprehensive Cancer Center, at the University of North Carolina at Chapel Hill, announced it received $40 million from the OpenAI Foundation. The UNC Health / UNC Lineberger newsroom post, dated September 15, 2026 and datelined Chapel Hill, N.C., is the filing event. These are UNC’s claims.

Purpose, as UNC tells it: generate data that could make personalized cancer vaccines more effective. A personalized cancer vaccine is a shot tailored to a patient’s tumor markers so the immune system targets that cancer. The center says researchers will use AI to identify stronger cancer-cell targets and guide more precise vaccines.

Named researchers, still UNC’s: immunologist Benjamin Vincent, MD, and computational biologist Alex Rubinsteyn, PhD. They are gathering clinical data; analyzing hundreds of de-identified tumor tissue and immune cells from three biobanks — stored tissue and cell samples for research; and comparing vaccine formulations in clinical trials for triple-negative breast cancer, a hard-to-treat subtype that lacks the usual hormone and HER2 targets.

Program claim, UNC plus a Foundation quote via UNC: the announcement coincides with the OpenAI Foundation launching its second science program, Public Data for Health — also called Data for Public Health in some coverage — aimed at high-quality open-access scientific datasets for life-science and disease research. An open-access dataset is research data other labs can reuse.com or openaifoundation.org dated program page.

On-record Foundation voice, via UNC: Jacob Trefethen, Head of Life Sciences and Curing Diseases at the OpenAI Foundation, said AI progress in cancer treatment depends on having the right biological data, and that UNC’s work will generate data at scale and make findings broadly available. His longer quotes stay in Sources.

Foundation identity, from UNC’s about blurb: OpenAI Foundation is described as a charitable organization and a separate nonprofit from OpenAI PBC that supports scientific discovery and public-benefit AI work. The same UNC lede also calls it the nonprofit parent that governs the for-profit company OpenAI Group PBC.

Plain English for the rest of the card: personalized cancer vaccine = a shot tailored to a patient’s tumor markers so the immune system targets that cancer. Biobank = stored tissue and cell samples for research. Open-access dataset = research data other labs can reuse. Triple-negative breast cancer = a hard-to-treat breast-cancer subtype that lacks common hormone and HER2 targets. Tumor antigen = a marker on cancer cells the immune system can learn to attack.